CNBC.com News Now: Whitney: No to Nationalization

Click here to view this newsletter on your mobile device. Thursday, Feb. 19, 2009     DOW 7465.95 -89.68 -1.19%   NASDAQ 1442.82 -25.15 -1.71%   S&P 778.94 -9.48 -1.2%       NEWS MARKETS EARNINGS INVESTING VIDEO CNBC TV CNBC PLUS     WHAT YOU SHOULD KNOW Dow Hits 6-Year Low as Banks Tank Stocks tumbled Thursday as anxiety over how the Obama administration will fix the crippled financial system pushed the Dow to its lowest level in more than six years... »read more Allen Stanford Found by FBI Agents, Served Papers FBI agents served the complaint from the U.S. Securities and Exchange Commission on Texas billionaire Allen Stanford in Virginia, an FBI spokesman said on Thursday... »read more Housing Plan: Five Things Investors Need to Know Investors hoping the government bailout will rescue the housing industry are making a risky bet, judging by analysts' reaction to the plan.... »read more TODAY'S TOP 5 VIDEOS 1. Santelli's Chicago Tea Party   The trading floor buzz on whether the government's plan to save the economy will actually help the markets, with Jason Roney, Sharmac Capital; Wilbur Ross Jr., WL Ross & Co. and CNBC's Rick Santelli 2. Whitney: No to Nationalization   Banking stocks are all lower today as the outlook for the industry fails to brighten. Meredith Whitney, CEO of the Meredith Whitney Advisory Group, has been on point with her outlook for financials and tells CNBC what's next for the sector 3. Swiss Fight to Stay Secret  The Swiss government is battling to retain the country's right to banking secrecy after UBS struck a deal with US authorities to transfer client data. Grace Annan from IHS Global Insight considers the implications. 4. Obama & Harper In Ottawa  President Obama and Canadian Prime Minister Stephen Harper announce a clean energy initiative and the importance of the relationship between the two North American countries. 5. Stop Trading, Listen to Cramer!   Mad Money's Jim Cramer shares his stock picks and pans with CNBC's Melissa Lee       TODAY'S TOP BLOG   Amgen's Epogen & Pedal Pushers The "Amgen Tour of California" is getting a lot more publicity than usual because superstar cyclists Lance Armstrong and Floyd Landis are trying to make comebacks in the race. But there's a certain irony that the biotech company that makes EPO, what is by nearly all accounts the most popular performance-enhancing drug among cyclists, is the major sponsor of a bike race featuring one defrocked, steroid-using racer and another one who has long been rumored to juice up. »See All CNBC.com Blogs     FIRST IN BUSINESS WORLDWIDE     (c)2009 CNBC Inc. All Rights Reserved 900 Sylvan Englewood Cliffs, NJ 07632

If you'd like to subscribe to this newsletter please visit our member center
Please note that cnbconline@cnbc.com is an unmonitored mailbox. To unsubscribe click here.